Maky Zanganeh, Chief Operating Officer at Summit Therapeutics Inc. (SMMT), bought 778,154 shares at $5.24 ($4.1M) on 2021-05-12, disclosed to the SEC on 2021-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.24 | 389,077 | $2.0M | 50.0% |
| 2 | $5.24 | 389,077 | $2.0M | 50.0% |
| Total | $5.24 avg | 778,154 | $4.1M | 100% |
| Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2018-03-28 | $190K | — | Filing → |
| PLSE | BUY | 2017-12-15 | $26K | — | Filing → |